Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
Clinical trial NCT01948180 · TERMINATED
Trial details
- NCT number
- NCT01948180
- Sponsor
- Cell Medica Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-04-16
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.